Medical Innovation Exchange

FDA Seeks Input on Advancing Use of Real-World Data and Evidence



The FDA is seeking input from stakeholders on how it should use user fee funding for engaging with external organizations, other than the National Evaluation System for Health Technology (NEST), to support premarket Real-World Evidence.

Under the fifth reauthorization of the Medical Device User Fees Amendments (MDUFA V), a portion of the current user fee funding is used to support the National Evaluation System for Health Technology (NEST) premarket Real-World Evidence (RWE) activities. In its request for public comment, the FDA said that it remains committed to work collaboratively to advance the development of Real-World Data (RWD) and use of RWE to evaluate device performance.

As part of this commitment and the FDA’s implementation of MDUFA V, the agency is asking stakeholders to submit public comments on how it should use any portion of the user fee funding that may be distributed to external organizations—other than NEST—to support premarket RWE.

Stakeholders can submit public comments through under docket number FDA-2023-N-0156. The 60-day public comment period will end on March 20, 2023.

For more information see Guidance for Industry and Food and Drug Administration Staff: Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices.

Related Articles

  • FDA

    The agency’s latest draft guidance is part of its strategy in creating a national evaluation system for medical devices.

  • The agency is providing an easy way for people to report misconduct in the medical device industry.

  • FDA

    The program aims to ensure that life-saving devices are available in battlefield settings.

  • MedTech Intelligence

    No longer just “the big company advantage,” CM&S is an accepted and viable device industry path to market for large and small medical device makers alike.


Original post:

Post publish date:


Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!